Cellular immune correlates of protection against symptomatic pandemic influenza - PubMed (original) (raw)

. 2013 Oct;19(10):1305-12.

doi: 10.1038/nm.3350. Epub 2013 Sep 22.

Affiliations

Cellular immune correlates of protection against symptomatic pandemic influenza

Saranya Sridhar et al. Nat Med. 2013 Oct.

Abstract

The role of T cells in mediating heterosubtypic protection against natural influenza illness in humans is uncertain. The 2009 H1N1 pandemic (pH1N1) provided a unique natural experiment to determine whether crossreactive cellular immunity limits symptomatic illness in antibody-naive individuals. We followed 342 healthy adults through the UK pandemic waves and correlated the responses of pre-existing T cells to the pH1N1 virus and conserved core protein epitopes with clinical outcomes after incident pH1N1 infection. Higher frequencies of pre-existing T cells to conserved CD8 epitopes were found in individuals who developed less severe illness, with total symptom score having the strongest inverse correlation with the frequency of interferon-γ (IFN-γ)(+) interleukin-2 (IL-2)(-) CD8(+) T cells (r = -0.6, P = 0.004). Within this functional CD8(+)IFN-γ(+)IL-2(-) population, cells with the CD45RA(+) chemokine (C-C) receptor 7 (CCR7)(-) phenotype inversely correlated with symptom score and had lung-homing and cytotoxic potential. In the absence of crossreactive neutralizing antibodies, CD8(+) T cells specific to conserved viral epitopes correlated with crossprotection against symptomatic influenza. This protective immune correlate could guide universal influenza vaccine development.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Lancet Infect Dis. 2009 Dec;9(12):784-8 - PubMed
    1. J Exp Med. 2005 Nov 21;202(10):1433-42 - PubMed
    1. J Exp Med. 2011 Jan 17;208(1):181-93 - PubMed
    1. Bull World Health Organ. 1959;20(2-3):297-301 - PubMed
    1. Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20365-70 - PubMed

Publication types

MeSH terms

LinkOut - more resources